Virtu Financial LLC Genetic Technologies LTD Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$0.8 - $1.13 $1,854 - $2,619	2,318 Added 14.61%	18,182 $15,000
Q1 2023 May 01, 2023	BUY	$0.86 - $1.82 $13,643 - $28,872	15,864 New	15,864 $19,000
Q2 2022 Aug 09, 2022	SELL	$0.0 - $0.01 $0 - $103	-10,310 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.0 - $0.0 $0 - $0	10,310 New	10,310 $20,000
Q4 2021 Feb 17, 2022	SELL	$0.0 - $0.01 $0 - $133	-13,357 Closed	0 $0

Q3 2021 Nov 12, 2021	BUY	$0.0 - $0.01 $0 - $133	13,357 New	13,357 $41,000
Q4 2020 Feb 24, 2021	SELL	$0.0 - $0.0 $0 - $0	-23,954 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$0.0 - $0.0 $0 - $0	6,265 Added 35.42%	23,954 $83,000
Q2 2020 Aug 07, 2020	BUY	$0.0 - $0.0 $0 - $0	17,689 New	17,689 $40,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $21.1M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.